FDA Regulatory Tuesday, August 25, 2026 +0.85 Positive

FDA Authorizes Wearable Monitoring Device for Blood Sugar, Ketones

The FDA approved the Libre Duo system for continuous monitoring of both blood sugar and ketone levels in people aged two and older living with diabetes.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day